[1]
X. Li, Z. Zhai, Y. Zhu, and H. Zhou, “Comparison of Gefitinib in the treatment of patients with non-small cell lung cancer and clinical effects of Osimertinib and EGFR Gene mutation”, Pak J Med Sci, vol. 38, no. 6, Jul. 2022.